Detailed molecular defmitlon of tbe WAGR region at chromosome llp13 bas been achleved by chromosome breakpoint analysis and long-range restrictlon mapping. Here we describe the molecular detedlon of a cytogenetlcally iDvis· ible l·megabase deletion ln an individual with anlridia, cryp· torcbiciism, and bypospadias but no WUms tumor (WT). The reglon of overlap between this deletion and one assodated witb WT and simUar genital anomalles but no anlridla covers a reglon of 350-400 kilobases, wblcb ls colncldent wlth the extent of homozygous deletlon detected in tumor tissue from a spo· radle WT. A candidate WT gene located wlthin this reglon has recently been isolated, suggesting nonpenetrance for tumor expression in the rarst iDdividual. The inclusion within tbe overlap region of a gene for WT predlsposltion and a gene for the best-documented WT -assodated genitourinary malforma· tions Ieads us to soggest that botb ofthese anomaUes result from a loss-of-function mutation at the same locus. Tbis in turn implies that the WT gene exerts plelotropic effect on both kidney and genitourinary development, a posslbUlty supported by the observed expresslon a)attern of the WT candidate gene ln developing kidney and gonads.
ABSTRACT
Detailed molecular defmitlon of tbe WAGR region at chromosome llp13 bas been achleved by chromosome breakpoint analysis and long-range restrictlon mapping. Here we describe the molecular detedlon of a cytogenetlcally iDvis· ible l·megabase deletion ln an individual with anlridia, cryp· torcbiciism, and bypospadias but no WUms tumor (WT). The reglon of overlap between this deletion and one assodated witb WT and simUar genital anomalles but no anlridla covers a reglon of 350-400 kilobases, wblcb ls colncldent wlth the extent of homozygous deletlon detected in tumor tissue from a spo· radle WT. A candidate WT gene located wlthin this reglon has recently been isolated, suggesting nonpenetrance for tumor expression in the rarst iDdividual. The inclusion within tbe overlap region of a gene for WT predlsposltion and a gene for the best-documented WT -assodated genitourinary malforma· tions Ieads us to soggest that botb ofthese anomaUes result from a loss-of-function mutation at the same locus. Tbis in turn implies that the WT gene exerts plelotropic effect on both kidney and genitourinary development, a posslbUlty supported by the observed expresslon a)attern of the WT candidate gene ln developing kidney and gonads.
Wilms tumor (WT) is a kidney malignancy-the most frequently seen solid tumor of childhood. Most cases are sporadic and unilateral, with no associated anomalies. Bilateral and familial tumors, comprising approximately 7% and 1% of the incidence, respectively (1), have an earlier age of onset than unilateral cases. On the basis of such statistics, the two-hit hypothesis formulated originally for retinoblastoma was extended to WT (2) . This model suggests that two mutational steps are required for the development of these childhood tumors. In the hereditary (bilateral and familial) cases, the first predisposing mutation is postulated to be present already in the germ-line and therefore present constitutively in all cells of the target tissue-hence, the earlier age of onset. In sporadic cases, two mutations have to accumulate postzygotically within the same target cell. N inety-five percentofall WT cases have presented by the age of 10 years (1), suggesting that the target-cell population disappears as development to mature form is completed.
Apart from rare familial incidence, the most clear-cut evidence for the presence of a predisposing DNA-Ievel change has come from the unexpectedly frequent association (1 in 100) of WT with aniridia (absence of iris) (3) . After this Observation, the diagnosis of sporadic aniridia in newbom infants, especially when accompanied by other anomalies, became a prognostic indicator for the possible development of WT. In many such cases, additional genitourinary abnorThe publication costs ofthis article were defrayed in part by page charge payment. This article must therefore be hereby marked "udvertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. 5383 malities and mental retardationarealso present-hence, the acronym W AGR for this syndrome. Karyotypic analysis of WAGR cases revealed the frequent presence of a deletion on one .chromosome 11 homolog, always including part of band llpl3 (4) . Only about 60% ofthe cases with a visible deletion develop WT, demonstrating that there is incomplete penetrance-presumably because no second mutation has occurred, although it should be bome in mind that deletions that do not include the WT locus may exist. However, genitourinary abnormalities, particularly in affected males, are seen at increased frequency, even in cases of sporadic WT, where no evidence of deletion can be found Glaser, and J. Pelletier. personal communication). There is also strong statistical evidence that genital-and kidney I urinary-system abnormalities are associated with early-onset (more frequently bilateral) WTs and with intralobar nephroblastomatosis (1, 5) . These associated anomalies are all hallmarks of the .. hereditary" tumor arising when there is a preexisting germ-line mutation. Therefore, their existence may result from the dominant etTects of constitutional mutation-the first "hit" at the WT locus.
In the course of localizing accurately and eventually cloning the genes ofthe WAGR region, using a number of deletion and translocation breakpoints, we have carried out molecular analysis of the llpl3 region in a child with incomplete WAGR syndrome. His abnormaJities comprise aniridia, genitourinary abnormalities, and mental retardation but no WT. Hybrid cell analysis and pulsed-field gel electrophoresis (PFGE) with previously mapped markers for the region revealed the loss of around 1 megabase (Mb) from one chromosome 11 homolog in this case, although no cytogenetic abnormality was visible.
Detailed molecular analysis also has been carried out on a second patient with a visible deletion at chromosome llpl3, who had WT, genitourinary abnormalities, but no aniridia (6) (7) (8) . The smallest region of overlap between these two deletions coincides with the extent of a rare WT -associated homozygous deletion region (9, 10) and includes the putative WT locus, for which a candidate genewas recently isolated (11) . From the clinical observations in these two constitutional deletion patients, the overlap region must also contain the gene(s) whose deletion Ieads to the associated genitourinary abnormalities.
On the basis of these results, we soggest that the WT gene may have pleiotropic effects on both kidney and genital Abbreviations: WT, Wilms tumor; WAGR, WT with aniridia, genitourinary anomalies, and mentaJ retardation triad; WT, gene for WT; AN2, chromosome llpl3-associated aniridia 2 gene (without WT, genitourinary anomaJies, and mental retardation); PFGE, pulsedfield gel electrophoresis; FSHB, gene for follicle-stimulating hormone ß; CALC, gene for calcitonin; CAT, gene for catalase. development, at least in males. This idea is supported by the elevated frequency of genitourinary anomalies accompanying WT and by the common embryological origins of the genital system and the metanephric kidney. The argument in favor ofthisdual role for the WT gene in the development of both the kidney and genital system is further strengthened by the pattem of expression of the recently isolated candidate gene for the WT locus.
MATERIALSAND METHODS
Clinical Summary and Cytogenetic Analysis. The patient, PAZO, presented initially with sporadic aniridia. Subsequently cryptorchidism (undescended testes) and hypospadias (misplaced penile extemal urinary orifice) were noted. Mild mental retardation and developmental delay were observed. No WT has been found in this boy, now age 12. Karyotype analysis of chromosome preparations from peripheral blood and later from the Epstein-Barr virustransformed lymphoblastoid cellline (12) revealed no abnormalities. In particular no deletion was detected on the chromosome 11 short arm.
The second patient, DAR, has been described in detail (13) . He presented with WT at age 21 months. There was no sign of aniridia or cataract. He required surgery to correct abnormal extemal genitalia: chordee (abnormally curved penis) and bilateral cryptorchidism. Karyotype analysis of chromosomes from peripheral blood cultures revealed deletion of most of band 11p13. Catalase activity was reduced, suggesting deletion of the locus CAT encoding this enzyme.
Somatic Cell Hybrids. Fusions were carried out between Epstein-Barr virus-transformed lymphoblastoid cells from the patients and mouse myeloma celllines as described (6, 12) . Stable celllines were selected by fluorescence-activated cell sorting and subcloning of live cells with high-level expression of appropriate human chromosome 11-encoded cell surface markers (6, 14) . The newly produced hybrids from the PAZO cell line were designated PAX and were analyzed for heterozygous marker alleles to ensure the presence of each chromosome 11 homolog in independent hybrids. DAR 15.4 has beeri described (6) .
DNA Markers. The derivation and characterization of the DNA markei's used in these analyses have been described in detail as follows: probes specific for follicle-stimulating hormone ß gene (FSHB) (19) .
Repeat-free probes used in this study have been described (8) . Additionally, JM44 is a 4.4-kilobase (kb) BamHI fragment from L65-6/74 DNA marker subcloned into pBiuescribe.
PFGE. High molecular weight DNA was prepared, and PFGE was perfoi'med as described (8) . Size markers were oligomers of phage A DNA and chroniosomes of Saccharomyces cerevisiae, strain YPH 148.
RESULTS
A series of PAX hybrids werc produced from the PAZO lymphoblastoid cell line known to be heterozygous for the polymorphic marker CALC. Analysis of these hybrids revealed that one allele was present in PAX 1 and the altemate allelein PAX 17, thus demonstrating the separation ofthe two chromosome 11 homologs (Fig. la) . Initial hybridization with available markers for the 11pl3 region showed no evidence of deletion, even with DNA markers such as NBC12 and L65-6/74, which were located close to the WTand AN2 loci (8) (Fig. 1 band c) . As further markers became available the hybrids were examined for their presence. In PAX 1, but not PAX 17, the markers Sl (Fig. ld) and 495 were deleted as weil as the intervening marker p5 (data not shown). Results are summarized in Fig.  2 , which illustrates the extent of deletions in the two patients described here.
The physical map of the WAGR region, summarized in Fig.  3 , suggested that the DNA matkers NBC12 and L65~/74 should closely flank the deletion in PAZO DNA (8) . Characterization of PAZO DNA by PFGE demonstrated that the proximal deletion breakpoint disrupts the 500-kb Not I fragment hybridizing to NBC12 (Fig. 4B) , although the proximal 90-kb regionoftbis fragmentwas unaltered (data not shown). In a similar manner, the distal deletion breakpoint interrupts the 1.4-megabase (Mb) BssHII fragment [these CpG island sites are coincident with Not I sites (8, 20) ] hybridizing to L65-6/74 (Fig. 4A) . The presence of an unaltered Sac II fragment restricts the position of this breakpoint to the centromeric 400 kb of the BssHII (Not I) fragment (20) . This fragment directly abuts the AN2 translocation, which has been studied in detail (21) .
The distal deletion breakpoint in the DAR parent lymphoblastoid line cannot be localized precisely. No altered Not I fragment could be detected with probe p5, which therefore places the deletion breakpoint proximal to the 325-kb fragment on which p5 resides (17) . DISCUSSION Molecular analysis of llp13 has allowed several groups to delineate a consensus map of the DNA in the WAGR region (7, 8, 17, 20) . In this study we have demonstrated the presence of a 1-Mb deletion in a patient with aniridia, hypospadias, cryptorchidism, and mental retardation but no WT. It is worth noting that a karyotypically undetectable deletion can involve loss of such a large amount of DNA.
The smallest region that must contain the WT locus has been refined by the deletions in DAR and in WiT13 DNAs. DAR is an individual with WT, cryptorchidism, and mild hypospadias but without aniridia-the case that clearly demonstrated the separate identities of the WT and AN2 genes, Horizontal divisions delineate the separate compartments, which have been defined by independent breakpoints. T-ALL, T-cell acute lymphocytic leukemi~t since the latter is considered to be a fully penetrant dominant mutation (7, 8, 22) . The position of the AN2 gene has also been defined at the molecular Ievel in aniridia-associated translocations (21, 22) . sporadic WT in a patient with no constitutional chromosome 11 deletion. However, the tumor itself was shown to be homozygously deleted for the llp13 marker SI (9). Subsequentanalysis ofthe two chromosome 11 homologs revealed independent overlapping deletions (10). The region of homozygous deletion is presumed to include the WT locus, and its existence permitted the isolation of a strong candidate for the WTgene (11) . Recently, homozygous deletions within the same small region were described in two further sporadic tumors and a second cloning of the same candidate WT gene was reported (23) . lt is only in the light of the location of these homozygous tumor-associated deletions that we could conclude that the patient P AZO, although nonpenetrant for tumor expression, must Iack the WT locus. Therefore, the smallest region of ov~rlap between the proximal breakpoint in P AZO DNA and the distal one in DAR DNA includes the WT gene and covers almost exactly the same 350..kb region as the homozygous deletion in WiT13 DNA (10) . lt is interesting to note that patients PAZO and DAR also share the hypospadias-cryptorchidism phenotype. This implies that a gene involved in aspects of male genital development also lies within the region of deletion overlap. Could it be that the gene involved in predisposition to WT also plays a roJe in genital development?
The candidate WT gene of Call et al. (11) was generously made available to us. Wehave been studying the expression pattem of this gene in normal development of early embryos. At the Ievel of RNA blot analysis, expression is clearly seen in fetal testis and ovary in addition to developing kidney (11, 29) . mRNA in situ hybridization in early embryos confirms the tissue distribution, showing strong expression in both metanephric and mesonephric kidney andin the early gonad (29) . These results are consistent with the hypothesis that the WT gene may have pleiotropic etlects on both kidney and genital development. Since correct early gonadal function inßuences subsequent genital development, mutation in this gene could account for the high frequency of cryptorchidism and hypospadias in male WT patients with or without aniridia (1, 5) .
In the case of aniridia-associated genitourinary abnormalities (four of five males among our patients with llpl3 deletion-associated aniridia, with or without WT, have cryptorchidism and/or hypospadias), the presence of a deletion (and therefore by definition a null allele) is implicated. It seems reasonable to suggest that similar genitourinary abnormalities seen in association with apparently "sporadic" WT are the result of germ-line or early zygotic mutation within the llpl3 region and perhaps within the single WT candidate locus. Since the candidate WT gene covers a genomic distance of only -so kb, there is room for other genes with influence on genital development in the 35().. to 400-kb overlap region between the deletions ofthe PAZO and DAR DNAs. However, the pleiotropy hypothesis can now be tested by looking for germ-line mutations at the WT locus in appropriate patients.
The possäble involvement of the WT candidate gene in gonadal development should be bome in mind when considering the documented Iack of affected offspring among 179 children of 99 surviving unilateral WT patients (24) . Such a large number of cases should include at least some with germ-line mutations (2) . Absence of WT transmission could be explained by suggesting that s.uch a constitutional change might render the carrier infertile or the carrier gametes nonviable. Consistent with this idea, where linkage studies of familial WT have been done, no llpl3 association has been seen (25, 26). Countertothis suggestion, however, there is evidence of at least partial fertility from observations of the Dickie Smalleye (Seyl>) mouse, which carries a WAGR-like chromosome 2 deletion encompassing loci that include the WT candidate and Sey, which may be the mouse aniridia gene homolog (27) . However, the validity ofthe mouse model for human disease may be questioned because the Sey 0 mouse also shows no predisposition to kidney tumors (27) . In addition, genetic control of fertility may ditler in mouse and man: for example, XO mice are usually fertile, while human XO individuals are virtually always sterile (28) .
To confirm involvement of the WT candidate gene in tumorigenesis and in genitourinary development, mutation analysis is required (i) at the mRNA or DNA Ievel in tumor tissue (11) and (ii) at the germ-line Ievel in candidate patients with WT accompanied by genitourinary anomalies. Only detailed functional analysis of this candidate gene-including the search for upstream control elements and downstream targets-will allow us to make the final conclusions about its Proc. Natl. Acad. Sei. USA 87 (1990) biological rote in both kidney and genital development. Meanwhile, the search continues for other genes of interest in this region of chromosome llp13. 
